News

Home / News

TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities

TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities

2023.9.6

...

More

TSH Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2023

TSH Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2023

2023.8.14

...

More

Expand New Therapeutic Area in Chronic Disease, TSH Entering Ophthalmic Market

Expand New Therapeutic Area in Chronic Disease, TSH Entering Ophthalmic Market

2023.7.13

...

More

TSH Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting

TSH Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting

2023.2.24

...

More

TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities

TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities

2023.3.7

...

More

To announce newly recommended Chairman

To announce newly recommended Chairman

2023.5.25

...

More